Frank Mattner

2.9k total citations
34 papers, 2.5k citations indexed

About

Frank Mattner is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Frank Mattner has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 15 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Frank Mattner's work include Alzheimer's disease research and treatments (13 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (6 papers). Frank Mattner is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (6 papers). Frank Mattner collaborates with scholars based in Austria, Switzerland and Germany. Frank Mattner's co-authors include Gottfried Alber, Maurice K. Gately, Achim Schneeberger, Jeanne Magram, Markus Mandler, Erwin Rüde, Tieno Germann, Edgar Schmitt, Shenchu Jin and Susanne Fischer and has published in prestigious journals such as PLoS ONE, Infection and Immunity and European Journal of Immunology.

In The Last Decade

Frank Mattner

34 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Mattner Austria 20 1.2k 519 405 361 327 34 2.5k
Yasmina Laouar United States 20 1.8k 1.5× 313 0.6× 532 1.3× 545 1.5× 716 2.2× 30 3.5k
Ikuo Tsunoda United States 35 1.2k 1.0× 505 1.0× 153 0.4× 340 0.9× 701 2.1× 118 3.1k
Francesco Ria Italy 29 1.3k 1.1× 328 0.6× 179 0.4× 180 0.5× 681 2.1× 84 2.6k
Ting Jia China 11 1.1k 1.0× 348 0.7× 269 0.7× 288 0.8× 785 2.4× 29 2.5k
Agnès Gardet United States 16 945 0.8× 562 1.1× 189 0.5× 204 0.6× 1.1k 3.5× 20 3.0k
Philip Y. Paterson United States 28 1.3k 1.1× 378 0.7× 136 0.3× 230 0.6× 910 2.8× 134 3.3k
Jan Ehrchen Germany 26 1.4k 1.2× 385 0.7× 189 0.5× 71 0.2× 958 2.9× 64 2.9k
Vincenzo Mitolo Italy 25 462 0.4× 269 0.5× 298 0.7× 77 0.2× 594 1.8× 75 1.7k
Todd N. Eagar United States 25 2.0k 1.7× 221 0.4× 221 0.5× 213 0.6× 599 1.8× 57 3.6k
Martin Kolev United Kingdom 19 1.7k 1.4× 284 0.5× 263 0.6× 63 0.2× 577 1.8× 41 2.6k

Countries citing papers authored by Frank Mattner

Since Specialization
Citations

This map shows the geographic impact of Frank Mattner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Mattner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Mattner more than expected).

Fields of papers citing papers by Frank Mattner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Mattner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Mattner. The network helps show where Frank Mattner may publish in the future.

Co-authorship network of co-authors of Frank Mattner

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Mattner. A scholar is included among the top collaborators of Frank Mattner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Mattner. Frank Mattner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneeberger, Achim, Suzanne Hendrix, Markus Mandler, et al.. (2015). RESULTS FROM A PHASE II STUDY TO ASSESS THE CLINICAL AND IMMUNOLOGICAL ACTIVITY OF AFFITOPE® AD02 IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE. The Journal of Prevention of Alzheimer s Disease. 2(2). 1–12. 32 indexed citations
2.
Mandler, Markus, Radmila Santic, P. Gruber, et al.. (2015). Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines. PLoS ONE. 10(1). e0115237–e0115237. 26 indexed citations
3.
Mandler, Markus, Elvira Valera, Edward Rockenstein, et al.. (2015). Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy. Molecular Neurodegeneration. 10(1). 10–10. 118 indexed citations
4.
5.
Galabova, Gergana, Sylvia Brunner, Petra Lührs, et al.. (2014). Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management. PLoS ONE. 9(12). e114469–e114469. 116 indexed citations
6.
Mandler, Markus, Elvira Valera, Edward Rockenstein, et al.. (2014). Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials. Acta Neuropathologica. 127(6). 861–879. 188 indexed citations
7.
Schneeberger, Achim, Markus Mandler, Frank Mattner, & Wolfgang Schmidt. (2011). Vaccination for Parkinson's disease. Parkinsonism & Related Disorders. 18. S11–S13. 57 indexed citations
8.
Schneeberger, Achim, Markus Mandler, Frank Mattner, & Walter Schmidt. (2010). AFFITOME® technology in neurodegenerative diseases: The doubling advantage. Human Vaccines. 6(11). 948–952. 42 indexed citations
9.
Schneeberger, Achim, Markus Mandler, Wolfgang Zauner, Frank Mattner, & Walter Schmidt. (2009). P1‐273: Development of Alzheimer AFFITOPE vaccines ‐ from concept to clinical testing. Alzheimer s & Dementia. 5(4S_Part_9). 2 indexed citations
10.
Fritz, Hervé, Sylvia Brunner, Max L. Birnstiel, et al.. (2004). The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens. Vaccine. 22(25-26). 3274–3284. 79 indexed citations
11.
Marschütz, Michaela K., et al.. (2002). Improvement of the enzymatic stability of a cytotoxic T-lymphocyte-epitope model peptide for its oral administration. Peptides. 23(10). 1727–1733. 23 indexed citations
12.
13.
Zauner, Wolfgang, Karen Lingnau, Frank Mattner, Alexander von Gabain, & Michael Buschle. (2001). Defined Synthetic Vaccines. Biological Chemistry. 382(4). 581–95. 21 indexed citations
14.
Mattner, Frank, Simona Smiroldo, Francesca Galbiati, et al.. (2000). Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3. European Journal of Immunology. 30(2). 498–508. 197 indexed citations
15.
Köhler, Gabriele, et al.. (1998). Interleukin-12 Is Essential for a Protective Th1 Response in Mice Infected withCryptococcus neoformans. Infection and Immunity. 66(10). 4994–5000. 261 indexed citations
16.
Mattner, Frank, Gottfried Alber, Jeanne Magram, & Manfred Köpf. (1997). The Role of IL-12 and IL-4 in Leishmania major Infection. PubMed. 68. 86–109. 12 indexed citations
17.
Mattner, Frank, Jeanne Magram, Pascal Launois, et al.. (1996). Genetically resistant mice lacking interleukin‐12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. European Journal of Immunology. 26(7). 1553–1559. 412 indexed citations
18.
Mattner, Frank, Susanne Fischer, Shenchu Jin, et al.. (1993). The interleukin‐12 subunit p40 specifically inhibits effects of the interleukin‐12 heterodimer. European Journal of Immunology. 23(9). 2202–2208. 245 indexed citations
19.
Germann, Tieno, Frank Mattner, Edgar Schmitt, et al.. (1992). Different accessory function for TH1 cells of bone marrow derived macrophages cultured in granulocyte macrophage colony stimulating factor or macrophage colony stimulating factor. International Immunology. 4(7). 755–764. 18 indexed citations
20.
Germann, Tieno, Shenchu Jin, Frank Mattner, & Erwin Rüde. (1991). Components of an antigen‐/T cell receptor‐independent pathway of lymphokine production. European Journal of Immunology. 21(8). 1857–1861. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasmina Laouar Breakdown of academic impact, for papers by Ikuo Tsunoda Breakdown of academic impact, for papers by Francesco Ria Breakdown of academic impact, for papers by Ting Jia Breakdown of academic impact, for papers by Agnès Gardet Breakdown of academic impact, for papers by Philip Y. Paterson Breakdown of academic impact, for papers by Jan Ehrchen Breakdown of academic impact, for papers by Vincenzo Mitolo Breakdown of academic impact, for papers by Todd N. Eagar Breakdown of academic impact, for papers by Martin Kolev
Rankless by CCL
2026